Literature DB >> 10536180

Telomerase activity in non-small cell lung carcinomas correlates with smoking status.

G Xinarianos1, F M Scott, T Liloglou, W Prime, J Callaghan, J R Gosney, J K Field.   

Abstract

Human telomerase is a ribonucleoprotein DNA polymerase which maintains the telomeric region of human chromosomes and has been detected in all types of human cancer tested. We used the telomeric repeat amplification protocol (TRAP) assay to examine 71 non-small cell lung carcinomas (NSCLC) and their adjacent normal tissue. Telomerase activity was detected in 61 (86%) of the 71 NSCLC examined but not in any of the matched normal lung tissues. A significant correlation was found between the presence of telomerase activity and current smoking status at the time of diagnosis (p=0. 0076). In addition, a trend was found between telomerase activity and smoking exposure (p=0.06). Our findings demonstrate that telomerase activity is a common phenomenon in NSCLC cases but not in the normal lung. However, certain cases in former smokers may follow a telomerase independent pathway.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10536180     DOI: 10.3892/ijo.15.5.961

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  3 in total

1.  Influence of DNA Mismatch Repair (MMR) System in Survival and Response to Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC): Retrospective Analysis.

Authors:  Alejandro Olivares-Hernández; Edel Del Barco Morillo; Carmen Parra Pérez; José Pablo Miramontes-González; Luis Figuero-Pérez; Teresa Martín-Gómez; Roberto Escala-Cornejo; Lorena Bellido Hernández; Rogelio González Sarmiento; Juan Jesús Cruz-Hernández; María Dolores Ludeña de la Cruz
Journal:  Biomedicines       Date:  2022-02-02

2.  Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours.

Authors:  S Lantuejoul; J C Soria; D Moro-Sibilot; L Morat; S Veyrenc; P Lorimier; P Y Brichon; L Sabatier; C Brambilla; E Brambilla
Journal:  Br J Cancer       Date:  2004-03-22       Impact factor: 7.640

3.  Can CYP1A1 siRNA be an effective treatment for lung cancer?

Authors:  Kulthum Mohammed; Amal Shervington
Journal:  Cell Mol Biol Lett       Date:  2008-04-10       Impact factor: 5.787

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.